Ladies and gentlemen, the following is an excerpt from my dissertation, which is still in progress. Due to the enormous amount of work involved, I am sure that every crucial point has been thoroughly analyzed, but accidental oversights are possible, so I would welcome your input in the form of additional (scientifically supported) data, preferably with references. I firmly believe that one of our most pressing problems (rapidly deteriorating global health), if not addressed, will have dire consequences, some of which could be transmitted to generations yet unborn. Therefore, disclosure of potential short and long-term side effects of birth control pill use is of great importance to the general welfare of society and the health of our nations.
In the 1960s, the Marxist-feminist apparatus (i.e., the women's rights movement) produced a newfangled narrative that disregards women's health for monetary and political gain. The mainstream narrative concerning sexual morality deteriorated as society moved away from traditional Christian values. New sex-exhorting products entered the market, the most well-known of which is the birth control pill. Thenceforth, the symbols of the Women's Rights Movement are birth control pills, casual sex, and abortion. In this section, I will introduce you to the intentionally omitted and/or neglected health risks associated with the birth control pill.
You may be wondering what could be so bad about birth control pills. After all, birth control pills are FDA-approved, so they are certainly not that bad. The government and the pharmaceutical industry would not lie to us. If you stop being ignorant and look at the research, you'll find tons of studies on the first five pages of Google touting the pill as a miracle that will liberate and empower women. Given that hormonal contraceptive use is a profitable business, one should not expect scientific evidence pointing to harmful effects to be over-publicized. Approximately 87% of women in the U.S. use contraceptives during their lifetime, with the birth control pill being the most commonly used reversible method, accounting for 21.9% of all contraceptives currently in use. In 2018, the global contraceptive pill market was $13.11 billion and is expected to reach $20.55 billion by 2026, suggesting that the industry currently has about 15 billion reasons not to disclose sensitive information.
The dark side of birth control pills is the saturation of consumers with the synthetic version of estrogen and progesterone designed to mimic natural estrogen and progesterone, resulting in the disruption of ovulation, menstruation, and the production of said hormones. Birth control pills (and copper IUDs) deplete zinc, iron, magnesium, selenium, and vitamins thiamine and C, setting off a vicious cycle of mineral imbalance and copper overload. How exactly does this happen? Synthetic estrogen-based pills decrease zinc levels. Whenever zinc levels go down, copper levels go up. High copper levels also increase estrogen levels. Copper affects the vaginal microbiome (the bacteria that regulate estrogen). High copper levels prevent the liver from removing the excess estrogen. In extreme cases, copper toxicity can lead to liver failure and death. Without adequate amounts of zinc and vitamin C, white blood cell production stops, and the immune system begins to fail. A deficiency of thiamine (B1) causes impairment of the nervous system. Other side effects of birth control pills include high candida (fungus) levels, breast, and cervical cancer, endometrial cancer, fibroids (tumors in the uterus), pituitary tumors, endometriosis, hypothyroidism, acne, high cortisol (i.e. insulin resistance and weight gain), ovarian cysts, increased risk of heart attack, high blood pressure, increased risk of stroke, venous thromboembolism (blood clots), dementia, depression, nausea, mood swings, Chloasma (hyperpigmentation), cervical exotropia, abnormal leukorrhea, hypermenorrhea, galactorrhea, choreiform movement disorders, hepatic effects, and numerous autoimmune diseases (especially lupus). Fetal exposure to exogenous estrogens and progestins has been associated with an increased risk of cardiac and neural tube defects. The primary cause of the above side effects is estrogen dominance (caused by synthetic estrogen derived from birth control pills, poisoned foods, water, etc.).
Since the 1960s, the use of OC has been associated with life-threatening health problems, e.g., heart attack, stroke, venous thromboembolism, breast and cervical cancer, mental illness, etc. The Royal College of General Practitioners reported that the risk of developing deep vein thrombosis in the legs is 550 percent higher in women taking birth control pills than in women not taking medication. Birth control pills containing high-dose androgenic progestins have been associated with abnormal glucose tolerance, which can lead to cardiovascular disease. On the other hand, low-dose OCs are associated with early, transient breakthrough bleeding. Taking OC during puberty leads to a blunted stress response and alters brain activation during working memory processing. OC is associated with increased prefrontal brain activation during working memory processing for negatively arousing stimuli and is also associated with significant structural changes in brain regions involved in memory and emotion processing.
Birth control pills alter mate preferences. Mr. Anthony C. Little examined the effects of oral contraceptive pill use on preferences and found that initiation of pill use significantly decreased women's preferences for male facial masculinity but had no influence on preferences for same-sex faces. To determine whether the change in preferences during pill use affected actual mate choice, he examined the facial features of 170 age-matched male partners of women who reported either being on the pill or not at the time of partner initiation. Both facial measurements and perceptual assessments showed that the partners of women who were using the pill at the time of partner selection had more feminine faces than the partners of women who were not using hormonal contraception at the time of partner initiation. Mr. Little concluded that the effects of pill use on mate choice processes have significant implications for relationship stability and may have other biologically relevant consequences as well. Several studies confirmed the validity of Little's thesis. One study found that high levels of cortisol (the primary stress hormone) make women more attracted to feminine traits. It is well known that women's preference for masculinity in male faces varies throughout the menstrual cycle. During the fertile phase of the menstrual cycle, women show a stronger preference for men with masculine features than during the nonfertile phases of the cycle. As mentioned earlier, the birth control pill shuts down ovulation, menstruation, and the production of estrogen and progesterone. In other words, the birth control pill increases relationship instability and decreases its chances of survival.
Lisa DeBruine, Benedict C Jones, David A Frederick, Martie G Haselton, Ian S Penton-Voak, David Perrett. - Evidence For Menstrual Cycle Shifts In Women's Preferences For Masculinity: a Response To Harris (in press) “Menstrual Cycle And Facial Preferences Reconsidered”. Evol Psychol. 2010 Dec 10;8(4):768-75.
Beate Ditzen, Simona Palm-Fischbacher, Lara Gossweiler, Livia Stucky, Ulrike Ehlert. - Effects Of Stress On Women's Preference For Male Facial Masculinity And Their Endocrine Correlates. Psychoneuroendocrinology. 2017 Aug;82:67-74. doi: 10.1016.
Anthony C Little, Tamsin K Saxton, S Craig Roberts, Benedict C Jones, Lisa M Debruine, Jovana Vukovic, David I Perrett, David R Feinberg, Todd Chenore. - Women's Preferences For Masculinity In Male Faces Are Highest During Reproductive Age Range And Lower Around Puberty And Post-Menopause. Psychoneuroendocrinology. 2010 Jul;35(6):912-20. doi: 10.1016.
Peterson HB, Lee NC. - LongTerm Health Risks And Benefits Of Oral Contraceptive Use. Obstet Gynecol Clin North Am. 1990 Dec;17(4):775-88.
Stenchever MA. - Risks Of Oral Contraceptive Use In Women Over 35. J Reprod Med. 1993 Dec;38(12 Suppl):1030-5.
Stubblefield PG. - Cardiovascular Effects Of Oral Contraceptives: a Review. Int J Fertil. 1989;34 Suppl:40-9.
Anthony C Little, Robert P Burriss, Marion Petrie, Benedict C Jones, S Craig Roberts. - Oral Contraceptive Use In Women Changes Preferences For Male Facial Masculinity And Is Associated With Partner Facial Masculinity. Psychoneuroendocrinology. 2013 Sep;38(9):1777-85. doi: 10.1016.
Elyse Lackie, Amy Fairchild. - The Birth Control Pill, Thromboembolic Disease, Science And The Media: a Historical Review Of The Relationship. Contraception. 2016 Oct;94(4):295-302. doi: 10.1016.
Julsrud ME. - A Review Of The Birth Control Pill And Its Relationship To Thrombophlebitis. J Am Podiatry Assoc. 1979 Jun;69(6):376-82. doi: 10.7547.
Naomi K Tepper, Polly A Marchbanks, Kathryn M Curtis. - Superficial Venous Disease And Combined Hormonal Contraceptives: a Systematic Review. Contraception. 2016 Sep;94(3):275-9. doi: 10.1016.
Atousa Aminzadeh, Ali Sabeti Sanat, Saeed Nik Akhtar. - Frequency Of Candidiasis And Colonization Of Candida Albicans In Relation To Oral Contraceptive Pills. Iran Red Crescent Med J. 2016 Aug 17;18(10):e38909. doi: 10.5812.
Ali Soroush, Negin Farshchian, Saeid Komasi, Neda Izadi, Nasrin Amirifard, Afshar Shahmohammadi. - The Role Of Oral Contraceptive Pills On Increased Risk Of Breast Cancer In Iranian Populations: A Meta-Analysis. J Cancer Prev. 2016 Dec; 21(4): 294–301.
Dawson K. - Side Effects Of Oral Contraceptives. Nurse Pract. 1979 Nov-Dec;4(6):53-5, 59.
Rupali Sharma, Samantha A Smith, Nadia Boukina, Aisa Dordari, Alana Mistry, Briallen C Taylor, Nereah Felix, Andrew Cameron, Zhuo Fang, Andra Smith, Nafissa Ismail. - Use Of The Birth Control Pill Affects Stress Reactivity And Brain Structure And Function. Horm Behav. 2020 Aug;124:104783. doi: 10.1016.
Pymar HC, Creinin MD. - The Risks Of Oral Contraceptive Pills. Semin Reprod Med. 2001 Dec;19(4):305-12. doi: 10.1055.
Stephanie Teal, Alison Edelman. - Contraception Selection, Effectiveness, And Adverse Effects: A Review. JAMA. 2021 Dec 28;326(24):2507-2518. doi: 10.1001.
